Home Health News In Abrupt Reversal, FDA Yanks Ixchiq Vaccine Over Safety Concern By News Health 2 months Ago Share on FacebookShare on Twitter (MedPage Today) — Just 2 weeks after lifting a pause on the use of the chikungunya live-attenuated vaccine (Ixchiq) in people 60 years and older, the FDA suspended the vaccine’s license entirely over “serious” safety concerns. The Center for… Source link : https://www.medpagetoday.com/publichealthpolicy/productalert/117140 Author : Publish date : 2025-08-25 17:04:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Medicare to Spend $15B on Treatment Linked to Fraud, Patient Harm By News Health October 27, 2025 More Trial Details Reported for Novel Psoriasis Pill By News Health October 27, 2025 Start With Four-Food Elimination Diet for EoE, Researchers Say By News Health October 27, 2025 Republicans Grapple With Voter Frustration Over Rising Healthcare Premiums By News Health October 27, 2025 Hormone Therapy Linked to Autoimmune Disease in Women By News Health October 27, 2025 AI Draws Even With Clinicians for Diabetes Prevention Intervention By News Health October 27, 2025